Home >> About >> News

Moulder Center and Temple School of Pharmacy's Launch Start-up Biotech Praeventix LLC Focused on IBD Therapies


Philadelphia, PA February 2, 2017 - A startup emerging from Temple University's School of Pharmacy builds on the work of two of its medicinal chemists and could potentially change the way inflammatory bowel disease is treated.  The company, Praeventix, is advancing a discovery made by the School of Pharmacy’s Daniel Canney and Benjamin Blass of the Moulder Center for Drug Discovery Research.

Temple University
Moulder Center for Drug Discovery Research

Temple University School of Pharmacy
3307 N Broad Street
Philadelphia, PA 19140